Brian Grow - 11 Aug 2025 Form 4 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
Chief Commercial Officer
Signature
/s/ William R. Kolb, Attorney-in-Fact
Issuer symbol
ORGO
Transactions as of
11 Aug 2025
Net transactions value
-$0.195
Form type
4
Filing time
13 Aug 2025, 16:08:38 UTC
Previous filing
21 Feb 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Grow Brian Chief Commercial Officer C/O ORGANOGENESIS HOLDINGS INC., 85 DAN ROAD, CANTON /s/ William R. Kolb, Attorney-in-Fact 13 Aug 2025 0001759142

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORGO Class A Common Stock Options Exercise $10,028 +4,060 +0.61% $2.47 674,550 11 Aug 2025 Direct
transaction ORGO Class A Common Stock Tax liability $10,028 -2,173 -0.32% $4.62 672,377 11 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORGO Stock Option (Right to Buy) Options Exercise $0 -4,060 -100% $0.000000 0 11 Aug 2025 Class A Common Stock 4,060 $2.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option are fully vested and exercisable.